CME Scientific Programme
22 February 2018 (Thursday)
“Current Concepts and Future Trends in Medicine”

Dr K S Shadaksharappa Hall
Time Session
08.30 - 9.30 WIN (What is new) Session Cardiology

CHAIRPERSONS: PC Manoria, Bhopal; A Muruganathan, Tirupur
  • Ventricular Premature Beats-When to Treat? SB Gupta, Mumbai
  • Spot Light on new drug therapies in Heart Failure: PC Manoria, Bhopal
  • STEMI care in India - How can we make a difference collectively: GS Wander, Ludhiana
09.30 – 10.30 Symposium on Stroke

CHAIRPERSONS: MPS Chawla, New Delhi; Bharat Panigrahi, Bhubaneswar
  • Current status of acute ischemic stroke therapy: Rohit Bhatia, New Delhi
  • Evaluation and management of TIAs: Subhash Kaul, Hyderabad
  • Update on management of anticoagulation induced Intracranial Hemorrhage: MV Padma Srivastava, New Delhi
10.30 - 11.00 Rabindranath Tagore Oration

CHAIRPERSONS: BR Bansode, Mumbai; Rohini Handa, New Delhi
  • Health and Disease in Women-From cradle to grave: T Geetha, Coimbatore
11.00 - 11.20 Inauguration of CME: Dr M Maiya, Bengaluru
11.20 - 11.45 Dean’s Oration

CHAIRPERSONS: Dr G Narsimulu, Hyderabad; Dr Amal Banerjee, Kolkata
  • What makes a good doctor better? Rohini Handa, New Delhi
11.45 - 12.45 Emerging Concepts in Rheumatology

CHAIRPERSONS: Vikram Londhey, Mumbai; Atul Kakar, New Delhi
  • Structural damage in axial SpA and role of TNF-inhibitors: PD Rath, New Delhi
  • JAK inhibition – A new treatment paradigm to treat RA: Vineeta Shobha, Bengaluru
  • Pneumococcal Vaccination- Need of the hour: BV Murali Mohan, Bengaluru
12.45 - 1.45 Diabetes & Inflammation

Chairs: Shashank R Joshi, Mumbai & AK Das, Puducherry
  • Inflammation and Diabetes- the Connect: Siddharth N. Shah, Mumbai
  • Role and Relevance of Hydroxychloroquine in the management of Type 2 Diabetes: Sarita Bajaj, Allahabad
  • Long term safety of Hydroxychloroquine in chronic medical conditions: S Chandrashekara, Bengaluru
1.45 - 2.45 Immunotherapeutics

CHAIRPERSONS: Milind Nadkar, Mumbai; Anil Gomber, New Delhi
  • Cytokine Modulation & Manipulation in Rheumatic Diseases: Bidyut Das, Cuttack
  • Fingerprint Adalimumab Biosimilar: Backing Science with Data: Shefali Khanna, Chandigarh
2.45 - 4.00 Panel Discussion on AMI
  • AMI: Optimizing outcomes, avoiding mishaps
    Moderator: PC Manoria, Bhopal
    Ashok Seth, New Delhi
    SS Iyengar, Bengaluru
    Amit Vora, Mumbai
    Sanjay Mittal, Gurgaon
    Vivek Jawali, Bengaluru